AIM ImmunoTech Announces Q2 2026 Financial Results

What Happened

• On August 10, 2026, AIM ImmunoTech Inc. announced its financial results for the quarter ended June 30, 2026 via a press release attached to an 8-K (Exhibit 99.1). The 8-K furnishes the press release and explicitly states the information is being furnished—not “filed”—for SEC purposes. The filing notes that quotes by Thomas Equels are included in the press release but are not incorporated by reference.

Key Details

• Item reported: 2.02 — Results of Operations and Financial Condition.
• Press release dated August 10, 2026 attached as Exhibit 99.1; Inline XBRL cover page included as Exhibit 104.
• The information is furnished (not filed) and therefore not subject to Section 18 Exchange Act liability or incorporation by reference into other SEC filings.
• The press release contains the company’s quarter‑end results for the period ending June 30, 2026 (read the attached release for revenue, net income/loss, and cash details).

Why It Matters

• This 8-K provides AIM’s latest quarterly results and company commentary—key facts investors use to assess recent earnings, revenue trends, and financial condition. Because the release is furnished rather than filed, it carries different legal treatment under SEC rules and may not be automatically incorporated into other filings. Investors should review the attached press release for the specific financial figures and monitor subsequent SEC filings or company communications for any further detail or explanation.